89 related articles for article (PubMed ID: 11803350)
1. Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis.
Akpek G; Lenz G; Lee SM; Sanchorawala V; Wright DG; Colarusso T; Waraska K; Lerner A; Vosburgh E; Skinner M; Comenzo RL
Bone Marrow Transplant; 2001 Dec; 28(12):1105-9. PubMed ID: 11803350
[TBL] [Abstract][Full Text] [Related]
2. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).
Reimer P; Kunzmann V; Wilhelm M; Weissbrich B; Kraemer D; Berghammer H; Weissinger F
Ann Hematol; 2003 May; 82(5):263-70. PubMed ID: 12739062
[TBL] [Abstract][Full Text] [Related]
3. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis.
Porrata LF; Gertz MA; Litzow MR; Lacy MQ; Dispenzieri A; Inwards DJ; Ansell SM; Micallef IN; Gastineau DA; Elliott M; Hogan WJ; Hayman SR; Tefferi A; Markovic SN
Clin Cancer Res; 2005 Feb; 11(3):1210-8. PubMed ID: 15709191
[TBL] [Abstract][Full Text] [Related]
4. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
5. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
Sanchorawala V; Wright DG; Quillen K; Finn KT; Dember LM; Berk JL; Doros G; Fisher C; Skinner M; Seldin DC
Bone Marrow Transplant; 2007 Sep; 40(6):557-62. PubMed ID: 17589534
[TBL] [Abstract][Full Text] [Related]
6. Renal response after high-dose melphalan and stem cell transplantation is a favorable marker in patients with primary systemic amyloidosis.
Leung N; Dispenzieri A; Fervenza FC; Lacy MQ; Villicana R; Cavalcante JL; Gertz MA
Am J Kidney Dis; 2005 Aug; 46(2):270-7. PubMed ID: 16112045
[TBL] [Abstract][Full Text] [Related]
7. Vaccination responses and lymphocyte subsets after autologous stem cell transplantation.
van der Velden AM; Claessen AM; van Velzen-Blad H; de Groot MR; Kramer MH; Biesma DH; Rijkers GT
Vaccine; 2007 Dec; 25(51):8512-7. PubMed ID: 17996989
[TBL] [Abstract][Full Text] [Related]
8. Rapid immune reconstitution following autologous hematopoietic stem cell transplantation in children: a single institution experience.
Hoepfner S; Haut PR; O'Gorman M; Kletzel M
Bone Marrow Transplant; 2003 Feb; 31(4):285-90. PubMed ID: 12621464
[TBL] [Abstract][Full Text] [Related]
9. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma.
Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP
Biol Blood Marrow Transplant; 2008 Jan; 14(1):116-24. PubMed ID: 18158968
[TBL] [Abstract][Full Text] [Related]
10. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
[TBL] [Abstract][Full Text] [Related]
11. Immune reconstitution and outcome after unrelated cord blood transplantation: a single paediatric institution experience.
Giraud P; Thuret I; Reviron D; Chambost H; Brunet C; Novakovitch G; Farnarier C; Michel G
Bone Marrow Transplant; 2000 Jan; 25(1):53-7. PubMed ID: 10654015
[TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
17. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.
Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL
Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229
[TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.
Avigan D; Wu Z; Joyce R; Elias A; Richardson P; McDermott D; Levine J; Kennedy L; Giallombardo N; Hurley D; Gong J; Kufe D
Bone Marrow Transplant; 2000 Jul; 26(2):169-76. PubMed ID: 10918427
[TBL] [Abstract][Full Text] [Related]
19. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
Joshi SS; Bishop MR; Lynch JC; Tarantolo SR; Abhyankar S; Bierman PJ; Vose JM; Geller RB; McGuirk J; Foran J; Bociek RG; Hadi A; Day SD; Armitage JO; Kessinger A; Pavletic ZS
Cytotherapy; 2003; 5(6):542-52. PubMed ID: 14660050
[TBL] [Abstract][Full Text] [Related]
20. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis.
Farge D; Henegar C; Carmagnat M; Daneshpouy M; Marjanovic Z; Rabian C; Ilie D; Douay C; Mounier N; Clave E; Bengoufa D; Cabane J; Marolleau JP; Gluckman E; Charron D; Toubert A
Arthritis Rheum; 2005 May; 52(5):1555-63. PubMed ID: 15880600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
